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Abstract
Objectives: There is debate concerning the best mode of delivery of analgesia following liver resection,
with continuous i.m. infusion of bupivacaine (CIB) plus patient-controlled i.v. analgesia (PCA) suggested
as an alternative to continuous epidural analgesia (CEA). This study compares these two modalities.
Methods: A total of 498 patients undergoing major hepatectomy between July 2004 and July 2011 were
included. Group 1 received CIB + PCA (n = 429) and Group 2 received CEA (n = 69). Groups were analysed
on baseline patient and surgical characteristics. Primary endpoints were pain severity scores and total
opioid consumption. Secondary endpoints were pain management failures, need for rescue medication,
postoperative (opioid-related) morbidity and hospital length of stay (LoS).
Results: In both groups pain was well controlled and >70% of patients had no or minimal pain on
PoDs 1 and 2. The numbers of patients experiencing severe pain were similar in both groups: PoD 1 at
rest: 0.3% in Group 1 and 0% in Group 2 (P = 1.000); PoD 1 on movement: 8% in Group 1 and 2% in
Group 2 (P = 0.338); PoD 2 at rest: 0% in Group 1 and 2% in Group 2 (P = 0.126), and PoD 2 on
movement: 5% in Group 1 and 5% in Group 2 (P = 1.000). Although the CIB + PCA group required more
opioid rescue medication on PoD 0 (53% versus 22%; P < 0.001), they used less opioids on PoDs 0–3
(P ≤ 0.001), had lower morbidity (26% versus 39%; P = 0.018), and a shorter LoS (7 days versus 8 days;
P = 0.005).
Conclusions: The combination of CIB + PCA provides pain control similar to that provided by CEA, but
facilitates lower opioid consumption after major hepatectomy. It has the potential to replace epidural
analgesia, thereby avoiding the occurrence of rare but serious complications.
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Introduction
The upper abdominal wall incision is a major contributor to post-
operative pain after liver resection.1,2 Given the continuing
increases in both the volume and extent of liver surgery, along
with the introduction of enhanced recovery programmes,3–7 there
is debate about the optimal method of delivering postoperative
analgesia. Effective postoperative pain control will reduce the inci-
dence of numerous postoperative complications, can facilitate
early mobilization and may result in earlier recovery.8,9 Pain
control is usually achieved by the administration of opioids, which
may cause side-effects, such as sedation, respiratory depression,
pruritus, hallucinations and postoperative nausea and vomiting
(PONV).
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Epidural analgesia has been considered superior to i.v. patient-
controlled analgesia (PCA) for postoperative pain relief in
patients recovering from major upper abdominal operations,10,11
although patient satisfaction with i.v. PCA is higher.11 However,
the use of epidural analgesia after hepatectomy is still subject to
debate. Because epidural analgesia can lead to serious complica-
tions, such as epidural abscess or haematoma,12 it may be
contraindicated when postoperative coagulopathy is expected.13,14
In addition, epidural methods take time to induce anaesthesia and
may not function adequately in up to 30% of patients.15
An alternative analgesic modality for the control of postopera-
tive pain is the continuous infiltration of local anaesthetic using
wound catheters placed in the abdominal wall.16–18 It is nearly a
decade since this method of postoperative pain management was
introduced in liver surgery and it has shown promising results.19,20
In other fields of surgery, the use of continuous wound infiltration
has suggested a reduction in costs.21–23 The most recent study, a
randomized controlled trial (RCT) performed by Revie et al. in
2012, demonstrated that local wound infiltration combined with
i.v. PCA, compared with continuous epidural analgesia (CEA),
reduced the time required to fulfil criteria for discharge from
hospital, but provided inferior analgesia.24
This retrospective study provides insights into the postopera-
tive analgesic merits of i.m. continuous infusion of bupivacaine
(CIB) combined with i.v. PCA, compared with mid-thoracic CEA
alone after major hepatic surgery.
Materials and methods
Patients
All open major hepatectomies (n = 545) performed in the
Hepatobiliary Unit of the North Hampshire Hospital in Basing-
stoke, UK, between July 2004 and July 2011 were included for
screening. Data were prospectively collected and stored in a dedi-
cated database by research staff blinded to the type of postopera-
tive analgesia. Data on postoperative milestones, such as day of
first oral intake and day of independent mobilization, were retro-
spectively added to the database after all available documentation
for both living and deceased patients had been reviewed. Primary
study endpoints were pain severity scores at rest and on move-
ment during the first 48 h postoperatively, and total opioid
requirements during the first 72 h postoperatively. Secondary
endpoints were pain management failures, need for rescue medi-
cation, opioid-related morbidity and hospital length of stay (LoS).
Surgery
General anaesthesia was induced with i.v. propofol (1.5–2.0 mg/kg)
and fentanyl (1–2 mcg/kg), with maintenance using volatile anaes-
thetics (iso-, des- or sevoflurane) in oxygen and air. For this study,
major hepatectomy was defined as resection of at least three liver
segments according to Couinaud’s classification.25 Hepatectomies
were performed by four liver surgeons (MR, FKSW, TGJ and ABC),
of whom only one (TGJ) used epidural catheters as the preferred
method of providing postoperative analgesia. Standard transection
techniques were used for liver resection under total or selective
hepatic vascular exclusion, as described previously.26,27 Unfavour-
able intraoperative incidents were graded according to the Satava
system for the evaluation of surgical error, adapted for liver
surgery.28 Postoperative morbidity was classified and analysed using
the Accordion system for grading surgical complications (with
Clavien–Dindo modifications), as described by Strasberg et al.29,30
Operating time was defined as the time between the first induction
of anaesthesia and the patient’s departure from the theatre. All
patients received antibiotic, and nausea and vomitus (PONV)
prophylaxis preoperatively. In the CIB + PCA group, PONV
prophylaxis (cyclizine or dexamethason on induction, ondansetron
postoperatively) was continued until PCA was removed.
Incision, wound closure and catheter placement
Access to the abdominal cavity was achieved with a right subcostal
incision31,32 extended to the bed of the right 12th rib laterally and
through the upper midline to the level of the xiphoid superiorly
(‘L’ incision). The skin incision was made by knife; diathermy was
used through subcutaneous tissue and muscles. Wound closure
and catheter placement techniques were also standardized and
have been previously described by Basu et al.19
Delivery of analgesic drugs
Immediately after wound closure, the i.m. catheters were flushed
with a 10-ml bolus of 0.25% bupivacaine, and continuous i.m.
catheter infusions of 0.25% bupivacaine were commenced at a
rate of 3 ml/h by syringe pump. This was continued for 72 h
postoperatively. Patient-controlled analgesia using morphine
(1 mg bolus with a 5-min lockout) or a fentanyl infusion (20 mcg
bolus with a 5-min lockout) was set up. In the CEA group, an
epidural catheter was sited before surgery in the thoracic T5–T12
region. This epidural catheter was also used to provide analgesia
during surgery (20 ml bupivacaine 0.25%). During emergence
from anaesthesia, the patient was transferred to the recovery area,
in which the PCA + CIB or CEA was started. The epidural infusion
of bupivacaine 0.1% with 2 mcg/ml fentanyl was set at 5–15 ml/h.
A dedicated pain team unaware of the type of hepatic resection or
any concomitant surgical procedure(s) assessed and scored the
patients daily until the i.v. or epidural analgesia could be stopped.
Pain intensity was scored using a verbal rating scale (VRS) ranging
from 0 (no pain) to 4 (worst imaginable pain). The level of seda-
tion was also measured on a 5-point scale (0 = awake, 1 = dosing
intermittently, 2 = sleeping and easy to wake, 3 = sleeping and
difficult to wake, 4 = unarousable). Wound and urinary catheters
were removed at the discretion of the operating surgeon, but
usually after 72 h [midnight on postoperative day (PoD) 3]. Pain
management failures in both groups were defined as the need for
rescue medication or a switch to a different opioid. The need for
rescue medication was defined as any additional epidural, i.v., i.m.
or oral administration of an opioid. A switch to a different analge-
sic protocol was defined as any change in analgesic medication,
concentration or infusion rate. In the event of the technical failure
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of the epidural catheter, the patient was commenced on PCA
with morphine or fentanyl. Oral analgesia [acetaminophen, non-
steroidal anti-inflammatory drugs (NSAIDs) and opioids] was
available in a standard manner to all patients. No standardized
enhanced recovery after surgery (ERAS) programme was imple-
mented during this study period.
Statistics
To facilitate comparisons between the two patient groups and the
different opioids, all opioids required were converted to an i.v.
morphine equivalent (Table 1). Comparisons between groups
were performed using Pearson’s chi-squared or Fisher’s exact test
for non-normally distributed categorical variables, as appropriate,
and the Mann–Whitney U-test or Kruskal–Wallis test for continu-
ous variables. All statistical tests were two-sided. A P-value of
< 0.05 was considered to indicate statistical significance. Statistical
analysis was performed using IBM spss Statistics for Windows
Version 19.0 (IBM Corp., Armonk, NY, USA).
Results
General and surgical characteristics
Of 545 patients identified in the database for the study period, a
total of 498 patients (CIB + PCA, n = 429; CEA, n = 69) underwent
major liver resection and were included in this study. For 41 of the
47 patients excluded, no data on opioid requirements could be
retrieved. This was mostly the result of either admission with
sedation to the intensive care unit (ICU) or the absence of fluid
balance/opioid infusion charts. Of the remaining six excluded
patients, four received PCA without CIB, and one received epi-
dural analgesia combined with CIB. No data at all could be
retrieved for the final patient. General patient characteristics are
shown in Table 2 and surgical characteristics in Table 3.
Table 1 Opioid conversion ratios
Conversion ratio References
Intravenous administration
Morphine 1:1
Fentanyl, mcg/ml 1:10 36–38
Epidural administration
Fentanyl, mcg/ml 3:10 39
Oral administration
Oxycodone 2:1 36
Morphine 3:1 36,38,40
Tramadol 15:1 36
Opioid conversion ratios lead to an i.v. morphine (mg/ml) equivalent.
Table 2 General characteristics of patients undergoing major hepatectomy in the present series
Epidural group (n = 69) CIB + PCA group (n = 429) P-value
Age, years, median (range) 63 (29–84) 63 (21–86) 0.695
Male sex, n (%) 42 (60.9%) 269 (62.7%) 0.770
BMI, kg/m2, median (range) 24.0 (20.0–33.5) 26.0 (16.0–44.0) 0.126
ASA physical status, n (%)
Class 1 2 (2.9%) 10 (2.3%) 0.673
Class 2 51 (73.9%) 320 (74.6%) 0.924
Class 3–5 13 (18.8%) 87 (20.3%) 0.828
Number of comorbidities, n (%)
0 37 (53.6%) 196 (45.7%) 0.240
1 19 (27.5%) 136 (31.7%) 0.466
2 6 (8.7%) 61 (14.2%) 0.190
≥3 7 (10.1%) 33 (7.7%) 0.498
Indication for surgery, n (%)
Colorectal metastases 56 (81.2%) 369 (86.0%) 0.290
Hepatocellular carcinoma 1 (1.4%) 4 (0.9%) 0.529
Cholangiocarcinoma (intrahepatic and hilar) 1 (1.4%) 12 (2.8%) 1.000
Other malignanciesa 3 (5.8%) 32 (7.4%) 0.453
Benign diseaseb 8 (10.1%) 12 (2.6%) 0.003
Previous abdominal surgery 59 (85.5%) 376 (87.6%) 0.324
CIB + PCA, i.m. continuous infusion of bupivacaine plus i.v. patient-controlled analgesia; BMI, body mass index; ASA, American Society of
Anesthesiologists.
A P-value of < 0.05 was considered to indicate statistical significance.
aOther malignancies include metastases of carcinoid, breast cancer, melanoma, neuroendocrine tumour, appendix carcinoma, ovarian carcinoma,
squamous cell carcinoma of the vagina, renal cell carcinoma, lymphoma, endometrial carcinoma, gastrointestinal stromal tumour, mixed type
hepatocellular carcinoma/cholangiocarcinoma, lymphoma and keratinizing squamous cell carcinoma.
bBenign diseases include cyst(s), adenoma, focal nodular hyperplasia, haemangioma and angiomyolipoma.
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Primary endpoints
The total median opioid consumption in milligrams (i.v.morphine
equivalent) was markedly lower in the CIB + PCA group (for all
time-points: P ≤ 0.001). However, postoperative pain was equally
well controlled in both groups (Table 4). The maximum percent-
ages of pain scores missing for the complete group of included
patients were 27.7% and 28.3% on PoDs 1 and 2, respectively.
Secondary endpoints
Intramuscular catheters were removed at a median of PoD 3
(range: PoD 2–5). Data on pain management failures, need for
rescue medication and technical failures are shown in Table 4.
Overall morbidity was higher in the epidural group (39.1%) than
in the CIB + PCA group (26.1%) (P = 0.030). Complication grades
rated on the Accordion system (with Clavien–Dindo modifica-
tions), length of hospital stay and readmissions are displayed in
Table 5. One death occurred in the epidural group (1.4%) and two
(0.5%) occurred in the CIB + PCA group (P = 0.361). The patient
in the epidural group died from myocardial infarction. In the
catheter group, one patient died from liver failure and the other
from multi-organ failure caused by severe sepsis after endoscopic
retrograde cholangiopancreatography (ERCP) for a bile leak. Spe-
cific complications per group are shown in Table 6. No instances
of respiratory depression were observed. There were no reported
cases of epidural hematoma, abscess formation or paralysis in the
group that received an epidural catheter.
Table 3 Operative characteristics of patients undergoing major hepatectomy in the present series
Epidural group
(n = 69)
CIB + PCA group
(n = 429)
P-value
Operating time, min, median (range) 260 (150–475) 260 (28–480) 0.356
Blood loss, ml, median (range) 295 (55–844) 369 (30–5344) 0.020
Incision, n (%)
Right subcostal 67 (97.1%) 425 (99.1%) 0.165
Othera 2 (2.9%) 4 (0.9%) 0.196
Segmental distribution of hepatectomies, n (%)
3 segments 8 (11.6%) 65 (15.2%) 0.438
3 segments + wedge 3 (4.3%) 26 (6.1%) 0.783
3 segments + multiple wedge 1 (1.4%) 9 (2.1%) 1.000
4 segments 40 (58.0%) 163 (38.0%) 0.002
4 segments + wedge 5 (7.2%) 70 (16.3%) 0.051
4 segments + multiple wedge 3 (4.3%) 25 (5.8%) 0.783
5 segments 5 (7.2%) 49 (11.4%) 0.301
5 segments + wedge 3 (4.3%) 13 (3.0%) 0.475
5 segments + multiple wedge 1 (1.4%) 6 (1.4%) 1.000
6 segments 0 3 (0.7%) 1.000
Additional procedures, n (%)
Cholecystectomy 13 (18.8%) 66 (15.4%) 0.478
Lymph node sampling 0 12 (2.8%) 0.387
Diaphragmatic resection 3 (4.3%) 18 (4.2%) 1.000
Roux-en-Y reconstruction 1 (1.4%) 3 (0.7%) 0.450
Right colectomy 1 (1.4%) 2 (0.5%) 0.361
Incisional hernia repair 0 3 (0.7%) 1.000
Ablation 0 6 (0.7%) 1.000
Otherb 2 (2.9%) 45 (11.2%) 0.046
Satava classification, n (%)
Grade I 0 17 (4.0%) 0.147
Grade II 0 2 (0.5%) 1.000
Grade III 0 1 (0.2%) 1.000
CIB + PCA, i.m. continuous infusion of bupivacaine plus i.v. patient-controlled analgesia.
A P-value of < 0.05 was considered to indicate statistical significance.
aOther incisions include abdominal longitudinal incision, Mercedes Benz incision and laparoscopic converted to open surgery.
bSee Appendix 1 for details.
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Table 4 Postoperative analgesia in patients undergoing major hepatectomy in the present series
Epidural group
(n = 69)
CIB + PCA group
(n = 429)
P-value
Time to discontinuation, days, median (range) 3 (1–5) 4 (1–8) 0.001
Cumulative opioid consumptiona, mg, median (range)
12 h 29.1 (0.0–266.0) 17.5 (0.0–1015.0) < 0.001
24 h 91.2 (5.0–1546.4) 43.0 (0.0–1225.0) <0.001
48 h 148.4 (6.0–1952.8) 58.0 (0.0–1625.0) <0.001
72 h 186.1 (4.0–1952.8) 61.0 (0.0–1650.0) <0.001
VRS score at rest PoD 1, n (%)
0 41 (89.1%) 234 (73.8%) 0.024
1 4 (8.7%) 69 (21.8%) 0.047
2 1 (2.2%) 13 (4.1%) 1.000
3 0 1 (0.3%) 1.000
4 0 0
VRS score on movement PoD 1, n (%)
0 29 (65.9%) 92 (29.4%) <0.001
1 11 (19.4%) 148 (46.8%) 0.006
2 3 (6.8%) 52 (16.4%) 0.118
3 1 (2.3%) 20 (6.3%) 0.491
4 0 4 (1.3%) 1.000
VRS score at rest PoD 2, n (%)
0 42 (93.3%) 273 (87.5%) 0.256
1 2 (4.4%) 32 (10.3%) 0.284
2 0 7 (2.2%) 0.603
3 1 (2.2%) 0 0.126
4 0 0
VRS score on movement PoD 2, n (%)
0 26 (59.1%) 134 (42.8%) 0.042
1 15 (34.1%) 118 (37.7%) 0.632
2 1 (2.3%) 45 (14.4%) 0.027
3 1 (2.3%) 16 (5.1%) 0.706
4 1 (2.3%) 0 0.124
Pain management failures, PoD 0–3b, n (%) 22 (31.9%) 231 (53.8%) 0.001
Opioid rescue medicationc, n (%)
PoD 0 15 (21.7%) 228 (53.1%) <0.001
PoD 1 3 (4.3%) 8 (1.9%) 0.185
PoD 2 5 (7.2%) 6 (1.4%) 0.010
PoD 3 6 (8.7%) 5 (1.2%) 0.002
Switch to different analgesic protocold, n (%) 14 (20.3%) 6 (1.4%) <0.001
Technical failure 14 (20.3%) 114 (26.6%) 0.268
Dislocation 7 (10.9%) 4 (0.9%)
Leakage 4 (6.3%) 1 (0.2%)
Occlusion 3 (4.7%%) 109 (25.8%)
CIB + PCA, i.m. continuous infusion of bupivacaine plus i.v. patient-controlled analgesia; PoD, postoperative day; VRS, verbal rating scale (0–4).
A P-value of < 0.05 was considered to indicate statistical significance.
aExpressed as i.v. morphine equivalent (any route).
bPain management failure: need for rescue medication or switch to different opioid.
cRescue medication: any additional intravenous, epidural, intramuscular or oral opioid.
dSwitch to different analgesic protocol: change of drug, concentration or infusion rate.
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Discussion
This study compared the analgesic value of CEA with that of CIB
+ PCA following major hepatectomy. Data for this large, retro-
spective cohort show that CIB + PCA provided analgesic control
equivalent to that of CEA. No significant differences in the
numbers of patients experiencing severe pain were observed
between the two groups and the majority of patients in both
groups had no or minimal pain during the first 48 h postopera-
tively. Strikingly, the CIB + PCA group consumed significantly
lower total volumes of opioids, had lower postoperative morbidity
and a decreased hospital LoS.
The present findings would appear to indicate that postopera-
tive pain was well controlled in both groups and that very few
patients experienced severe pain on PoDs 1 and 2. In addition,
most patients (>70%) in both groups had zero or minimal pain at
rest or on movement. There is little practical difference between
level 0 and level 1 pain, but ‘no pain’ and ‘severe pain’ lie at either
end of any pain intensity scale and thus it seems safe to conclude
that the present findings are reliable. The use of CIB + PCA also
led to a substantial decrease in opioid consumption without com-
promising pain control. The decrease in opioid consumption was
expected and can be explained by two factors. Unlike those in the
CIB + PCA group, patients with epidurals were not able to control
their opioid administration. In addition, the local analgesic effect
of bupivacaine reduces the need for i.v. opioid infusion. Interest-
ingly, patients with wound catheters were discharged 1 day earlier
than those in the epidural group, at a median of 7 days rather than
8 days (P = 0.005).
An increased need for rescue medication in the CIB + PCA group
was observed. In most patients rescue medication was given on the
day of surgery (PoD 0),but this was countered by an increased need
for rescue medication and a switch to i.v. opioids in the CEA group
on PoDs 1–3. In addition, CIB + PCA was continued for 1 day
longer than epidural analgesia. This mainly reflects the practical-
ities of managing epidurals as it is part of postoperative practice to
remove the catheter after 72 h unless otherwise clinically indicated.
The high percentage (53.1%) of patients requiring rescue medica-
tion may be explained by the possibility that the local analgesic
effect of the bupivacaine infusion may have been suboptimal
directly after surgery. The epidural analgesia was started prior to
the incision, whereas the wound catheters were commenced
immediately after wound closure. It may take time for bupivacaine
to reach all adjacent tissue and associated nerve endings. Unlike a
correctly functioning epidural analgesic, which provides a com-
plete block, bupivacaine infusion exhibits only a local effect and
additional opioids may be required.
Another important result refers to the finding that when one of
the catheters was dislodged or occluded (often by a faulty connec-
tor or by the faulty insertion of the catheter into the connector),
pain control was adequately maintained by just one catheter. This
is supported by the stagnant opioid consumption on PoDs 2 and
3 with adequate maintenance of pain control. This implies that a
single infusing catheter combined with PCA may be sufficient to
control postoperative pain.
The findings of this study are in keeping with those of earlier
reports on the beneficial results of this technique with regard to
pain control, opioid consumption and recovery.16,19,24,33 It has been
claimed that epidural analgesia is superior to PCA for postopera-
tive pain relief in patients recovering from major upper abdomi-
nal operations.10,11 However, the present study shows that when
PCA is combined with CIB via i.m. catheters, equivalent pain
control can be achieved. As Khorgami et al.34 demonstrated in a
recent RCT, the technique of local interfascial analgesia is also
feasible for midline incisions.
The present results confirm the clinical applicability of wound
catheters. Not only does this analgesic approach provide equivalent
pain control with reduced opioid intake, but it also represents a
quicker and very likely cheaper method of doing so. Abandoning
the use of epidural analgesia eliminates the risk for epidural-related
complications (haematoma, abscess and nerve damage) and may
improve cost-effectiveness as anaesthetic time may be shortened
Table 5 Postoperative outcomes in patients undergoing major hepatectomy in the present series
Epidural group
(n = 69)
CIB + PCA group
(n = 429)
P-value
Complications (Accordion Classification), n (%)
Grade I 3 (4.3%) 16 (3.7%) 0.737
Grade II 10 (14.5%) 31 (7.2%) 0.057
Grade III 0 14 (3.3%) 0.235
Grade IV 11 (15.9%) 40 (9.3%) 0.130
Grade V 2 (2.9%) 7 (1.6%) 0.361
Grade VI (death) 1 (1.4%) 2 (0.5%) 0.361
Length of stay, days, median (range) 8 (3–80) 7 (3–95) 0.005
Readmissions (<30 days), n (%) 2 (2.9%) 15 (3.5%) 1.000
CIB + PCA, i.m. continuous infusion of bupivacaine plus i.v. patient-controlled analgesia.
A P-value of < 0.05 was considered to indicate statistical significance.
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and the CIB + PCA combination does not require specialist super-
vision on the ward. The lower total opiate dose received may also
reduce opiate-associated side-effects. In patients in whom experts
aim to achieve faster postoperative recovery within the context of
an ERAS programme, the use of CIB + PCA may result in a further
reduction in the time required to meet recovery criteria.
The partly retrospective design of this study resulted in the
incomplete availability of pain scores. The complete availability of
pain data might have altered the comparability of the groups and
might have implied an increased superiority or inferiority of
either of the two analgesic modalities. In addition, an inherent
bias of surgeon preference influencing outcomes cannot be
excluded. The strengths of this study include its use of a large and
uninterrupted cohort of patients submitted to major liver resec-
tion in an expert centre, whereas other prospective series are con-
siderably smaller. The patients investigated in this study represent
Table 6 Morbidity in patients undergoing major hepatectomy in the present series
Epidural group
(n = 69)
CIB + PCA group
(n = 429)
P-value
Overall morbidity, n (%) 27 (39.1%) 112 (26.1%) 0.030
Complications, n (%)
Bile leak 2 (2.9%) 16 (3.7%)
Liver failure 13 (18.8%) 43 (10.0%)
Sepsis 0 5 (1.2%)
Abdominal abscess 1 (1.4%) 4 (0.9%)
Ileus 0 5 (1.2%)
Pneumonia 3 (4.3%) 11 (2.6%)
Pleural effusion 1 (1.4%) 4 (0.9%)
Myocardial infarction 1 (1.4%) 2 (0.5%)
Wound infection 1 (1.4%) 11 (2.6%)
Renal failure 2 (2.9%) 7 (1.6%)
Postoperative haemorrhage 0 4 (0.9%)
Peritonitis 0 2 (0.5%)
Ascites 1 (1.4%) 8 (1.9%)
Biliary stricture/stenosis 0 4 (0.9%)
Multi-organ failure 1 (1.4%) 4 (0.9%)
Pneumothorax 0 2 (0.5%)
Urinary tract infection 2 (2.9%) 6 (1.4%)
Atrial fibrillation 3 (4.3%) 2 (0.5%)
Other 2 (2.9%) 12 (2.8%)
Analgesia-related morbidity (all), n (%) 29 (45.3%) 169 (41.4%) 0.558
Pruritus 14 (20.3%) 92 (21.4%)
Hallucinations 7 (10.1%) 80 (18.6%)
Dizziness 4 (5.8%) 32 (7.5%)
Hypotension requiring treatment 5 (7.2%) 0
Acute confused episode 3 (4.3%) 4 (0.9%)
Wound infection 1 (1.4%) 11 (2.6%)
Urinary retention 0 3 (0.7%)
Sedation score PoD 1
0 37 (82.2%) 215 (59.9%) 0.004
1 8 (17.8%) 129 (35.9%) 0.015
≥2 0 15 (4.2%) 0.392
CIB + PCA, i.m. continuous infusion of bupivacaine plus i.v. patient-controlled analgesia; PoD, postoperative day.
A P-value of < 0.05 was considered to indicate statistical significance.
Other complications include: haematoma at resection area (n = 1), transient ischaemic attack (n = 1), Horner's syndrome (n = 1), pulmonary embolism
(n = 1), respiratory failure (n = 1), alcohol withdrawal (n = 1), deep vein thrombosis (n = 1), infected line (n = 1), allergic reaction (n = 1), sacral pressure
sore (n = 1), cellulites (n = 1), partial portal vein thrombosis (n = 1), axillary nerve palsy (n = 1) and cerebral infarct (n = 1).
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a population at risk for postoperative coagulopathy and the devel-
opment of epidural hematoma.
It would be interesting for future research to compare patient-
controlled epidural analgesia with CIB + PCA and to look into the
number and location of wound catheters needed to achieve the
optimal local analgesic effect. Lastly, it would be interesting to
compare the local wound infusion technique with that of the
transversus abdominis plane block,35 which can also be regarded
as safe and effective after abdominal surgery.
Conclusions
Continuous i.m. bupivacaine infusion with i.v. PCA provides
equivalent pain control and a lower level of opioid consumption
compared with CEA following major hepatectomy. The CIB +
PCA technique could replace that of epidural analgesia with the
potential for greater safety, improved postoperative outcomes and
a reduced hospital LoS.
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Appendix 1
The following (combined) procedures were performed only twice in the study cohort:Cholecystectomy + biliodigestive anastomosis,
skeletonization of the hepatoduodenal ligament, closure of ileostomy, block dissection of the hepatoduodenal ligament, cava resection, node
block dissection of the lesser sac, diaphragm + peritoneal nodule resection, cholecystectomy + hepatoduodenal ligament biopsy, deroofing
of a liver cyst and excision of peritoneal deposits not in the lesser sac.
The following (combined) procedures were performed only once in the study cohort:En bloc gastric resection + cholecystectomy, block
dissection of the hepatoduodenal ligament + diathermy ablation, excision of aortocaval lymph node + peritoneal deposit resection,
skeletonization of the hepatoduodenal ligament + Roux loop biliary reconstruction + cholecystectomy, block dissection of the lesser sac +
excision of the common bile duct + Roux loop reconstruction, colon excision + cholecystectomy, reconstruction of the v. cava, right
hemicolectomy + diathermy ablation, sleeve resection of the duodenum, posterior pelvic extenteration, en bloc total mesorectal excision +
appendicectomy + excision of a mesenteric mass, diaphragm resection and repair of two incisional hernias, cholecystectomy + excision of the
greater omentum, exploration of common bile duct + removal of a stone, splenectomy, insertion of terminal ileostomy, gastroduodenal ligament
+ cholecystectomy, vascular reconstructions, nephrectomy + adrenalectomy, block dissection of the lesser sac + excision of common bile
duct + Roux loop reconstruction + repair of an incisional hernia, reconstruction of the bile duct, small bowel resection, small bowel biopsy
and resection of part of the diaphragm and lung.
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